Cutaneous lupus erythematosus patients in a high‐epidemic COVID ‐19 area, Bergamo, Italy
- Resource Type
- Authors
- G. Imberti; Marco Di Mercurio; Andrea Carugno; Daniele Gambini; Angelo Francesco Castagna; Pamela Vezzoli; Elisa Robustelli Test; Paolo Sena
- Source
- Dermatologic Therapy
- Subject
- Adult
Male
medicine.medical_specialty
2019-20 coronavirus outbreak
Letter
hydroxychloroquine
Coronavirus disease 2019 (COVID-19)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Pneumonia, Viral
Comorbidity
Dermatology
SARS‐CoV‐2
Betacoronavirus
Young Adult
Lupus Erythematosus, Cutaneous
medicine
Humans
Letters
Pandemics
Aged
Aged, 80 and over
Lupus erythematosus
SARS-CoV-2
business.industry
lupus erythematosus, COVID-19
COVID-19
Hydroxychloroquine
General Medicine
Middle Aged
medicine.disease
cutaneous lupus erythematosus
Italy
Cutaneous Lupus Erythematosus
Female
coronavirus disease 2019 (COVID‐19)
Coronavirus Infections
business
lupus erythematosus
medicine.drug
- Language
- English
- ISSN
- 1529-8019
1396-0296